Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Research

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8118824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.

  1993cited by this paper
• Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.

  1993cited by this paper
• Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic‐pathologic correlations

  1993cited by this paper
• Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

  1993cited by this paper
• Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11.

  1992cited by this paper
• Suppression of tumorigenicity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosome 11.

  1992cited by this paper
• Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma.

  1992cited by this paper
• Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma.

  1992cited by this paper
• Sequence identification of 2,375 human brain genes

  1992cited by this paper
• Loss of constitutional heterozygosity in human cancer.

  1991cited by this paper
• Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.

  1991cited by this paper
• Accumulation of genetic alterations and progression of primary breast cancer.

  1991cited by this paper
• Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11.

  1991cited by this paper
• Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.

  1991cited by this paper
• Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18

  1991cited by this paper
• Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.

  1991cited by this paper
• Human tumor suppressor genes.

  1990cited by this paper
• Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.

  1990cited by this paper
• Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes.

  1990cited by this paper
• 1P13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer

  1990cited by this paper
• Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas.

  1990cited by this paper
• Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

  1990cited by this paper
• Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.

  1989cited by this paper
• New approach for isolation of VNTR markers.

  1988cited by this paper
• Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

  1988cited by this paper
• Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.

  1987cited by this paper
• Multiple Taq I RFLPs at the human manganese superoxide dismutase (S0D2) locus on chromosome 6.

  1987cited by this paper
• Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia.

  1987cited by this paper
• Chromosome 6 in malignant melanoma.

  1983cited by this paper

• Identification of a novel Eps 15 homology domain-containing protein 1 (EHD1) and EHD4-binding motif in phostensin.

  2025cites this paper
• Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis

  2022cites this paper
• Parkin: A targetable linchpin in human malignancies.

  2021cites this paper
• Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer

  2021cites this paper
• Investigation of the Involvement of Parkin in Parkinson's Disease and Cancer by Monitoring the Changes in SH-SY5Y Cells at the Nuclear Proteome Level

  2020cites this paper
• Identification of phostensin in association with Eps 15 homology domain-containing protein 1 (EHD1) and EHD4.

  2020cites this paper
• Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene

  2019cites this paper
• A rare eicosanoid precursor analogue, sciadonic acid (5Z,11Z,14Z-20:3), detected in vivo in hormone positive breast cancer tissue.

  2018cites this paper
• The effects of chromosome number changes on mitotic fidelity and karyotype stability

  2015cites this paper
• Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model.

  2014cites this paper
• Identification of the High Molecular Weight Isoform of Phostensin

  2014cites this paper
• A sparse ising model with covariates

  2014cites this paper
• Unsaturated Fatty Acids, Desaturases, and Human Health

  2014cites this paper
• Identification and functional analysis of genes associated with oncogenesis

  2013cites this paper
• Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation

  2013cites this paper
• Mixed and Covariate Dependent Graphical Models.

  2013cites this paper
• Analyse intégrative génomique et épigénomique de tumeurs hypophysaires à prolactine

  2013cites this paper
• Sparse Ising Models with Covariates

  2012cites this paper
• KISS1 and Its G Protein-Coupled Receptor (GPR54) in Cancer Progression and Metastasis

  2012cites this paper
• Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors

  2011cites this paper
• Recent Advances in Breast Cancer Metastasis Suppressor 1

  2011cites this paper
• Restoration of senescence in breast and ovarian cancer cells following the transfer of the YAC carrying SEN6A gene located at 6q16.3.

  2011cites this paper
• Tumor and Stem Cell Biology Haploinsufficiency in the Prometastasis Kiss 1 Receptor Gpr 54 Delays Breast Tumor Initiation , Progression , and Lung Metastasis

  2011cites this paper
• Parkinson's disease and cancer: two wars, one front

  2011cites this paper
• FADS2 Function Loss at the Cancer Hotspot 11q13 Locus Diverts Lipid Signaling Precursor Synthesis to Unusual Eicosanoid Fatty Acids

  2011cites this paper
• Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.

  2011cites this paper
• How mitotic errors contribute to karyotypic diversity in cancer.

  2011cites this paper
• Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis

  2010influential citation
• Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells*

  2010cites this paper
• Genetic and phenotypic characterization of the lymphocytic variant of the Hypereosinophilic Syndrome : a model of T lymphomagenesis

  2010cites this paper
• In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6.

  2009influential citation
• Analyse der freien zirkulierenden DNA von Prostatakarzinom-Patienten auf allelische Imbalance

  2009cites this paper
• LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer

  2009influential citation
• LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast cancer - eScholarship

  2008cites this paper
• Diffuse Malignant Mesothelioma: Genetic Pathways and Mechanisms of Oncogenesis of Asbestos and Other Agents That Cause Mesotheliomas

  2008cites this paper
• Parkin as a tumor suppressor gene for hepatocellular carcinoma

  2008cites this paper
• Dissecting the molecular mechanisms of cancer through bioinformatics‐based experimental approaches

  2007cites this paper
• Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.

  2007cites this paper
• UTRN on chromosome 6q24 is mutated in multiple tumors

  2007cites this paper
• Allelic imbalance at 11q23-q24 chromosome associated with estrogen and radiation-induced breast cancer progression.

  2006cites this paper
• Characterization of Frequently Deleted 6q Locus in Prostate Cancer

  2006cites this paper
• Allelic imbalance at 11 q 23-q 24 chromosome associated with estrogen and radiation-induced breast cancer progression

  2006cites this paper
• Advances in Brief Suppression of Fibrosarcoma Metastasis by Elevated Expression of Manganese Superoxide Dismutase 1

  2006cites this paper
• An epigenetic approach for identifying novel tumor associated genes from regions of loss of heterozygosity in human neoplasias.

  2005cites this paper
• The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer

  2005cites this paper
• Analysis of Different Deleted Regions in Chromosome 11 and Their Interrelations in Early- and Late-Onset Breast Tumors: Association with Cyclin D1 Amplification and Survival

  2004cites this paper
• Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update

  2004cites this paper
• Cytogenetic evaluation of 20 primary breast carcinomas.

  2004cites this paper
• Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T‐cell lymphoma

  2003cites this paper
• Allelic imbalance at 11p15.5–15.4 correlated with c‐Ha‐ras mutation during radiation‐induced neoplastic transformation of human breast epithelial cells

  2003cites this paper
• Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin‐2 expression in human salivary gland carcinomas

  2003cites this paper
• Transfer of chromosome 8 into two breast cancer cell lines: total exclusion of three regions indicates location of putative in vitro growth suppressor genes.

  2003cites this paper
• The quest for a tumor suppressor gene phenotype.

  2003cites this paper
• Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27

  2003cites this paper
• The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene

  2003cites this paper
• Microcell-mediated chromosome transfer (MMCT): small cells with huge potential

  2003cites this paper
• Deletion of chromosome bands 11q22-q23 in lymphoproliferative disorders and the genetics of mantle cell lymphoma

  2002cites this paper
• Methodologies in cancer cytogenetics and molecular cytogenetics.

  2002cites this paper
• Loss of heterozygosity on chromosome 11 in esophageal squamous cell carcinomas.

  2002cites this paper
• Characterization of Mice Deficient in the Src Family Nonreceptor Tyrosine Kinase Frk/rak

  2002cites this paper
• DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer

  2002cites this paper
• Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer

  2002cites this paper
• Malignant Lymphoma and Tumor Suppressor Genes

  2002cites this paper
• Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization.

  2002cites this paper
• Tamoxifen enhancement of TNF-α induced MnSOD expression: modulation of NF-κB dimerization

  2002cites this paper
• Mapping of nasopharyngeal carcinoma tumor‐suppressive activity to a 1.8‐megabase region of chromosome band 11q13

  2002cites this paper
• Induction of cellular senescence in a telomerase negative human immortal fibroblast cell line, LCS-AF.1-3, by human chromosome 6.

  2002cites this paper
• Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk.

  2002cites this paper
• Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities

  2001cites this paper
• Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells.

  2001cites this paper
• Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.

  2001cites this paper
• Disruption of the ATM gene in breast cancer.

  2001cites this paper
• Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11.

  2001cites this paper
• SV40-mediated immortalization.

  2001cites this paper
• A human melanoma metastasis‐suppressor locus maps to 6q16.3‐q23

  2000cites this paper
• Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia.

  2000cites this paper
• Altered Expression of the ERM Proteins in Lung Adenocarcinoma

  2000cites this paper
• Molecular analysis of the h-warts/LATS1 gene in human breast cancer.

  2000cites this paper
• Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines

  2000cites this paper
• Chromosome 6q deletions in gastric carcinoma : A Positional cloning approach to isolate cDNAs at 6q16.3-q23.3 = Delecções do braço longo do cromossoma 6 em carcinomas gástricos : Isolamento de cDNAs em 6q16.3-q23.3 por clonagem posicional

  2000cites this paper
• At least five regions of imbalance on 6q in breast tumors, combining losses and gains

  2000cites this paper
• A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach

  2000cites this paper
• A 3‐cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization

  2000cites this paper
• Genetics of Cutaneous Malignant Melanoma

  1999cites this paper
• Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer

  1999cites this paper
• A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region.

  1999cites this paper
• Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma

  1999cites this paper
• Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility.

  1999cites this paper
• Genetic aberrations and their clinical significance in breast and ovarian cancer

  1999cites this paper
• Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region

  1999cites this paper
• Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells

  1999cites this paper
• The Role of Tumor Suppressor Genes in Breast Cancer Progression

  1999cites this paper
• European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables

  1999cites this paper
• Loss of heterozygosity of the Wilms' tumor suppressor gene (WT1) in in situ and invasive breast carcinoma.

  1999cites this paper
• 11q23.1 and 11q25-qter YACs suppress tumour growth in vivo

  1999cites this paper
• Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.

  1999cites this paper
• Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD

  1999cites this paper
• Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma

  1999cites this paper
• Transcriptional map of chromosome region 6q16→q21

  1999cites this paper
• Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors

  1999cites this paper